Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine wound infiltration concentration comparison after pediatric inguinal hernia repair
2008-007996-26Phase 3Terminated
- Sponsor
- IRCCS Burlo Garofolo
- Start
- Dec 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ropivacaine in postoperative pain (3 arms), sponsored by IRCCS Burlo Garofolo. Primary endpoints: Postoperative pain control over 24 hours, CHEOPS pain scores and 1 more. Started Dec 2008; status: terminated.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on 2008-007996-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-007996-26.